FDA-Drug2026-10-14Class IIPROCESSING DEFECT

Carolina Infusion Tri-MIX injectable recalled for sterility assurance issue

OTHERNationwide distributionDrugs

What this means

Carolina Infusion, LLC is recalling Tri-MIX (papaverine/phentolamine/alprostadil) injectable medication due to a lack of assurance of sterility. The issue is related to processing equipment used to compound the product. The affected medication was packaged in single-use dosage syringes and distributed nationwide.

  • If you have received Tri-MIX from Carolina Infusion with lot numbers 08072026@2 (expires 9/21/2026) or 08032026@10 (expires 9/17/2026), contact your healthcare provider or pharmacy immediately.
  • Do not use the product without first speaking to your healthcare provider about the recall and next steps.
  • Your healthcare provider can advise whether you need an alternative medication or additional monitoring.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Related to processing equipment used in compounded product.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the U.S
Affected count
15 mLs - in patient specific syringe doses
Manufactured in
95 Bees Creek Rd, N/A, Ridgeland, SC, United States
Products
Tri-MIX (PAPAV/PHENTO/ALPROS),30/1/20, injectable, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936,

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0022-2027

More Carolina Infusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.